Thus, shared decision-making between surgical, anesthetic, and medical teams is essential to balance risks and benefits [111]
Rong Y, Gao J, Kuang T, Chen J, Li JA, Huang Y, et al
The primary preclinical evidence comes from mouse studies showing reduced body weight and adipose mass in diet-induced obese mice (2018), improved grip strength in aged mice (2024), and beneficial microbiome changes when combined with caloric restriction (2022)
Glucagon-like peptide-1 in diabetes care: can glycaemic control be achieved without nausea and vomiting
Ongoing use may be needed to maintain weight loss, as stopping the medication often leads to gradual weight regain, especially in the absence of lifestyle changes